BridgeMD
New treatment option for Overactive Bladder (OAB)
Official title Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function
ClinicalTrials.gov ID: NCT06944392
What this study is testing
- What it's testing
- This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.
- Time commitment: about 12 weeks
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without...
You likely can't join if
- Patients with any of the following will be excluded from the study:
- Use of other supplements that contain pumpkin seed oil
- ≥Stage 3 pelvic organ prolapse
- Urinary post-void residual ≥150cc
- Culture-proven urinary tract infection at time of study enrollment
- Recurrent urinary tract infection
See the full eligibility criteria
- All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without...
- Patients with any of the following will be excluded from the study:
- Use of other supplements that contain pumpkin seed oil
- ≥Stage 3 pelvic organ prolapse
- Urinary post-void residual ≥150cc
- Culture-proven urinary tract infection at time of study enrollment
- Recurrent urinary tract infection
- Neurogenic bladder
- Abdominal or pelvic malignancy
- Initiation of new overactive bladder medications or supplements during study period or in the 3 months immediately preceding study enrollment
- History of surgery in the past 12 months for pelvic organ prolapse, stress urinary incontinence, urgency urinary incontinence, or fecal or flatal incontinence
- Patient's primary language is not English
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.